Over the last several years, parties interested in acquiring, investing in, licensing from, or collaborating with U.S. businesses—particularly those working with exciting and novel technologies—have been forced to grapple extensively with a wide range of regulations concerning national security, and 2022 has been no different. Between the Committee on Foreign Investment in the United States, export controls, sanctions, anti-money laundering, and government contracts rules, a new emphasis on U.S. national security regulation has touched companies across the board. Abroad, too, a number of new developments in these fields continue to show that national security is no longer a regulatory touchstone for the United States alone—a trend we expect to continue into 2023.

In our report we summarize some of the most significant developments in national security regulation in 2022 and discuss early expectations for 2023—in both cases, changes that will impact how technology companies, life sciences companies, and their partners and investors will interact for years to come.

Click here to read the report.